Global Lyme Disease Market and Competitive Landscape – 2017
The latest research from Fore Pharma, Global Lyme Disease Market and Competitive Landscape – 2017, provides comprehensive insights into Lyme Disease pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Lyme Disease market size and drug sales. This research also provides insights into Lyme Disease epidemiology and late stage pipeline.
The report is classified into twelve sections – Lyme Disease overview with definitions, symptoms, etiology, diagnosis, treatment options; Lyme Disease pipeline insights covering late stage clinical trials pipeline; Lyme Disease prevalence trends by countries; Lyme Disease market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.
Research Scope:
- Lyme Disease pipeline: Find out the drugs in clinical trials for Lyme Disease by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
- Lyme Disease epidemiology: Find out the prevalence of Lyme Disease by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
- Lyme Disease products: Identify key products marketed and prescribed for Lyme Disease by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
- Lyme Disease market size: Find out the market size for Lyme Disease drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
- Lyme Disease drug sales: Find out the sales of Lyme Disease drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
- Lyme Disease drugs sales forecast: Sales forecast for Lyme Disease drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
- Lyme Disease market share analysis: Find out the market shares of Lyme Disease drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
- Evaluate commercial market opportunities for Lyme Disease drugs
- Synthesize insights for business development & licensing
- Track market size, competitor drug sales, market shares in Lyme Disease market
- Develop in-depth knowledge of competition and markets
- Analyze sales data to update your brand planning trackers
- Develop tactics and strategies to take advantage of opportunities in the market
- Track market trends and analyze key events in Lyme Disease market
- Develop forecast models, healthcare frameworks, or economic models
- Answer key business questions; supports decision making in R&D to long term marketing strategies
- 1. Lyme Disease: Disease Overview
- 1.1. Lyme Disease Symptoms
- 1.2. Lyme Disease Etiology
- 1.3. Lyme Disease Diagnosis
- 1.4. Lyme Disease Treatment Options
- 2. Lyme Disease Pipeline Insights
- 2.1. Lyme Disease Phase 3 Clinical Trials
- 2.2. Lyme Disease Phase 2 Clinical Trials
- 2.3. Lyme Disease Phase 1 Clinical Trials
- 3. Lyme Disease Epidemiology Analysis
- 4. US Lyme Disease Market Insights
- 4.1. Marketed Products for Lyme Disease in US
- 4.2. US Lyme Disease Market Size & Forecast
- 4.3. US Lyme Disease Product Sales Forecast
- 4.4. US Lyme Disease Market Share Analysis
- 5. Germany Lyme Disease Market Insights
- 5.1. Marketed Products for Lyme Disease in Germany
- 5.2. Germany Lyme Disease Market Size & Forecast
- 5.3. Germany Lyme Disease Product Sales Forecast
- 5.4. Germany Lyme Disease Market Share Analysis
- 6. France Lyme Disease Market Insights
- 6.1. Marketed Products for Lyme Disease in France
- 6.2. France Lyme Disease Market Size & Forecast
- 6.3. France Lyme Disease Product Sales Forecast
- 6.4. France Lyme Disease Market Share Analysis
- 7. Italy Lyme Disease Market Insights
- 7.1. Marketed Products for Lyme Disease in Italy
- 7.2. Italy Lyme Disease Market Size & Forecast
- 7.3. Italy Lyme Disease Product Sales Forecast
- 7.4. Italy Lyme Disease Market Share Analysis
- 8. Spain Lyme Disease Market Insights
- 8.1. Marketed Products for Lyme Disease in Spain
- 8.2. Spain Lyme Disease Market Size & Forecast
- 8.3. Spain Lyme Disease Product Sales Forecast
- 8.4. Spain Lyme Disease Market Share Analysis
- 9. UK Lyme Disease Market Insights
- 9.1. Marketed Products for Lyme Disease in UK
- 9.2. UK Lyme Disease Market Size & Forecast
- 9.3. UK Lyme Disease Product Sales Forecast
- 9.4. UK Lyme Disease Market Share Analysis
- 10. Europe Lyme Disease Market Insights
- 10.1. Europe Lyme Disease Market Size & Forecast
- 10.2. Europe Lyme Disease Product Sales Forecast
- 10.3. Europe Lyme Disease Market Share Analysis
- 11. Japan Lyme Disease Market Insights
- 11.1. Marketed Products for Lyme Disease in Japan
- 11.2. Japan Lyme Disease Market Size & Forecast
- 11.3. Japan Lyme Disease Product Sales Forecast
- 11.4. Japan Lyme Disease Market Share Analysis
- 12. Global Lyme Disease Market Insights
- 12.1. Global Lyme Disease Market Size & Forecast
- 12.2. Global Lyme Disease Product Sales Forecast
- 12.3. Global Lyme Disease Market Share Analysis
- 13. Research Methodology
- LIST OF TABLES
- Table 1: Lyme Disease Phase 3 Clinical Trials, Global, 2017
- Table 2: Lyme Disease Phase 2 Clinical Trials, Global, 2017
- Table 3: Lyme Disease Phase 1 Clinical Trials, Global, 2017
- Table 4: Lyme Disease Prevalence by G7 Countries, 2012 - 2021
- Table 5: Marketed Products for Lyme Disease in US, 2017
- Table 6: US Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 7: US Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 8: US Lyme Disease Market Trends, 2012 - 2021
- Table 9: Marketed Products for Lyme Disease in Germany, 2017
- Table 10: Germany Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 11: Germany Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 12: Germany Lyme Disease Market Trends, 2012 - 2021
- Table 13: Marketed Products for Lyme Disease in France, 2017
- Table 14: France Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 15: France Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 16: France Lyme Disease Market Trends, 2012 - 2021
- Table 17: Marketed Products for Lyme Disease in Italy, 2017
- Table 18: Italy Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 19: Italy Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 20: Italy Lyme Disease Market Trends, 2012 - 2021
- Table 21: Marketed Products for Lyme Disease in Spain, 2017
- Table 22: Spain Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 23: Spain Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 24: Spain Lyme Disease Market Trends, 2012 - 2021
- Table 25: Marketed Products for Lyme Disease in UK, 2017
- Table 26: UK Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 27: UK Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 28: UK Lyme Disease Market Trends, 2012 - 2021
- Table 29: Europe Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 30: Europe Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 31: Marketed Products for Lyme Disease in Japan, 2017
- Table 32: Japan Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 33: Japan Lyme Disease Product Sales ($mn), 2012 - 2021
- Table 34: Japan Lyme Disease Market Trends, 2012 - 2021
- Table 35: Global Lyme Disease Market Size & Forecast ($mn), 2012 - 2021
- Table 36: Global Lyme Disease Product Sales ($mn), 2012 - 2021
- LIST OF FIGURES
- Figure 1: Lyme Disease Pipeline by Phase (%), Global, 2017
- Figure 2: Lyme Disease Prevalence by G7 Countries, 2012 - 2021
- Figure 3: US Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 4: US Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 5: US Lyme Disease Market Share by Products (%), 2016
- Figure 6: US Lyme Disease Market - Future Market Share (%), 2021
- Figure 7: Germany Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 8: Germany Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 9: Germany Lyme Disease Market Share by Products (%), 2016
- Figure 10: Germany Lyme Disease Market - Future Market Share (%), 2021
- Figure 11: France Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 12: France Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 13: France Lyme Disease Market Share by Products (%), 2016
- Figure 14: France Lyme Disease Market - Future Market Share (%), 2021
- Figure 15: Italy Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 16: Italy Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 17: Italy Lyme Disease Market Share by Products (%), 2016
- Figure 18: Italy Lyme Disease Market - Future Market Share (%), 2021
- Figure 19: Spain Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 20: Spain Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 21: Spain Lyme Disease Market Share by Products (%), 2016
- Figure 22: Spain Lyme Disease Market - Future Market Share (%), 2021
- Figure 23: UK Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 24: UK Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 25: UK Lyme Disease Market Share by Products (%), 2016
- Figure 26: UK Lyme Disease Market - Future Market Share (%), 2021
- Figure 27: Europe Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 28: Europe Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 29: Europe Lyme Disease Market Share by Products (%), 2016
- Figure 30: Europe Lyme Disease Market - Future Market Share (%), 2021
- Figure 31: Japan Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 32: Japan Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 33: Japan Lyme Disease Market Share by Products (%), 2016
- Figure 34: Japan Lyme Disease Market - Future Market Share (%), 2021
- Figure 35: Global Lyme Disease Market Size ($mn), 2012 - 2021
- Figure 36: Global Lyme Disease Product Sales ($mn), 2012 - 2021
- Figure 37: Global Lyme Disease Market Share by Products (%), 2016
- Figure 38: Global Lyme Disease Market - Future Market Share (%), 2021